Gilead Sciences CEO Daniel O’Day told CNBC on Monday the company is continuing to study new...
remdesivir
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment...
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment...
Gilead Sciences announced new findings Friday that its antiviral drug remdesivir reduced the risk of...
New cases of the coronavirus continued to surge over the weekend across several U.S....
Gilead Sciences announced Monday the much-anticipated pricing for its coronavirus treatment remdesivir, saying it will...
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment...
A pharmacy tech holds a bottle and a pill of Hydroxychloroquine at Rock Canyon...
Even as some countries, particularly those first hit by the coronavirus, show some positive...
A lab technician inspects filled vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir...
